New improved formulation for treatment of thromboembolism

Details New improved formulation for treatment of thromboembolism New improved formulation for treatment of thromboembolism

A - Human Necessities

61

K

A61K 38/55 (2006.01) A61K 9/127 (2006.01) A61K 9/48 (2006.01) A61K 47/14 (2006.01) A61P 7/02 (2006.01)

Patent

CA 2253410

A new pharmaceutical formulation comprising the thrombin inhibitor HOOC-CH2- (R)-Cgl-Aze-Pab in combination with medium chain glycerides, a process for the preparation of such a pharmaceutical formulation, the use of such formulation in the treatment of thromboembolism as well as a method of treating a patient in need of such a treatment by using said formulation.

On décrit une nouvelle formulation pharmaceutique comprenant l'inhibiteur de la thrombine, HOOC-CH¿2?-(R)-Cgl-Aze-Pab, combiné à des glycérides à chaîne moyenne, un procédé de préparation d'une telle formulation, l'utilisation de celle-ci dans le traitement des thromboembolies, ainsi qu'une méthode de traitement d'un patient nécessitant une telle thérapie, au moyen de cette formulation.

Affiliated with

Also associated with

Rating

New improved formulation for treatment of thromboembolism does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with New improved formulation for treatment of thromboembolism, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New improved formulation for treatment of thromboembolism will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2000872